NCT02990455

Brief Summary

The proposed research will investigate whether smokers with vs. without current at-risk alcohol drinking (ARD) respond to reduced nicotine cigarettes by increasing their alcohol consumption or smoke exposure, thereby diminishing the hypothesized public health benefit of these new products.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Nov 2017

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 7, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 13, 2016

Completed
11 months until next milestone

Study Start

First participant enrolled

November 14, 2017

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 21, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 21, 2021

Completed
Last Updated

September 29, 2021

Status Verified

September 1, 2021

Enrollment Period

3.4 years

First QC Date

December 7, 2016

Last Update Submit

September 27, 2021

Conditions

Keywords

alcoholdrinkingsmokingcigarettenicotine

Outcome Measures

Primary Outcomes (1)

  • Alcohol drinks per day

    7 days

Secondary Outcomes (3)

  • Toxicant exposure

    7 days

  • Subjective acceptability

    7 days

  • Smoking compensation

    7 days

Study Arms (2)

Reduced Nicotine Cigarette - Moderate

EXPERIMENTAL

Nicotine Research Cigarette Drug Supply Program Category Codes NRC600 and NRC601 (menthol); each cigarette contains 0.8mg nicotine; participants will be instructed to smoke these cigarettes according to their usual smoking patterns

Drug: Reduced nicotine cigarettes

Reduced Nicotine Cigarette - Low

EXPERIMENTAL

Nicotine Research Cigarette Drug Supply Program Category Codes NRC102 and NRC103 (menthol); each cigarette contains 0.03mg nicotine; participants will be instructed to smoke these cigarettes according to their usual smoking patterns

Drug: Reduced nicotine cigarettes

Interventions

Participants will be assigned to undergo two experimental conditions (i.e., exclusive smoking of RNC Low or Moderate in their home environment for 7 days) in a double-blind, randomized, crossover design. The two experimental conditions will be separated by a 7-day period of return to smoking of participants' own brand of cigarette.

Also known as: Nicotine research cigarettes
Reduced Nicotine Cigarette - LowReduced Nicotine Cigarette - Moderate

Eligibility Criteria

Age21 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ages 21-65;
  • Smokes ≥ 10 cigarettes/day for ≥ 2 years;
  • Has no immediate plans to quit drinking or smoking; and
  • Sufficient understanding of informed consent form and study procedures.

You may not qualify if:

  • Has or is at-risk of serious alcohol-related consequences, defined as any of the following:
  • Meets DSM-5 criteria for current alcohol use disorder with the presence of 6 or more symptoms (i.e., current severity of severe)
  • Has a Clinical Institute Withdrawal Assessment scale score of ≥8,
  • Self-report of history of seizures, delirium, or hallucinations during alcohol withdrawal;
  • Self-report of drinking to avoid withdrawal symptoms, or
  • Self-report of a history of alcohol withdrawal treatment.
  • Women if pregnant, lactating, or not using a reliable form of birth control;
  • Has current serious psychiatric disorder;
  • Has DSM-5 current severe substance use disorder, other than nicotine;
  • Has current use of smokeless tobacco, pipes, cigars, e-cigarettes, or nicotine replacement products;
  • Displays clinically evident intoxication on any study visit, confirmed by breathalyzer test (breath alcohol level (BAL)\>0.02 mg%);
  • Has difficulties with blood draws or poor venous access; or
  • Has significant smoking-related disease (by history).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Battelle Memorial Institute

Baltimore, Maryland, 21209, United States

Location

MeSH Terms

Conditions

Alcohol DrinkingSmoking

Condition Hierarchy (Ancestors)

Drinking BehaviorBehavior

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 7, 2016

First Posted

December 13, 2016

Study Start

November 14, 2017

Primary Completion

April 21, 2021

Study Completion

April 21, 2021

Last Updated

September 29, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations